Description
- Large chemical company that manufactures synthetic magnesium compounds
- Compounds are used in the polymer production and processing industry worldwide
- Based in the Netherlands and part of a strong international group
- Hi-tech production facility equipped for growth
- Strong management with R&D skills and a focus on sustainability
- Very healthy financial performance
Transaction rationale
The client has a clear diversification and growth strategy and is looking for acquisition targets in the inorganic pharmaceutical industry in the EU.
Key Financials
Target description
- Pharmaceutical companies (production and/or wholesale) with own storage facilities/distribution centre
- Location within the European Union
- EBITDA range between €500k million – €5 million
- Preferably a stand-alone business, however if necessary, it can be integrated into the Dutch operations
- Products must be inorganic
EBITDA-range
€500k – 5M.
